Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centella Asiatica-derived exosomes are nanovesicles derived from the plant *Centella asiatica*, known for its triterpenoid-rich profile and use in wound healing and skin rejuvenation. These exosomes encapsulate bioactive molecules and have been shown to promote collagen synthesis, reduce oxidative stress, enhance wound healing, and exhibit anti-inflammatory effects. They are researched for their potential in skincare applications, including improving skin elasticity, hydration, and reducing signs of aging. The mechanisms of action include reducing intracellular reactive oxygen species (ROS), inhibiting melanin synthesis, and modulating inflammatory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Centella Asiatica-derived exosomes.